List of Tables
Table 1. Global Cytomegalovirus (HHV-5) Infection Therapeutic Drugs Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
Table 2. Key Players of Oral Medication
Table 3. Key Players of Injection
Table 4. Global Cytomegalovirus (HHV-5) Infection Therapeutic Drugs Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
Table 5. Global Cytomegalovirus (HHV-5) Infection Therapeutic Drugs Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 6. Global Cytomegalovirus (HHV-5) Infection Therapeutic Drugs Market Size by Region (2019-2024) & (US$ Million)
Table 7. Global Cytomegalovirus (HHV-5) Infection Therapeutic Drugs Market Share by Region (2019-2024)
Table 8. Global Cytomegalovirus (HHV-5) Infection Therapeutic Drugs Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 9. Global Cytomegalovirus (HHV-5) Infection Therapeutic Drugs Market Share by Region (2025-2030)
Table 10. Cytomegalovirus (HHV-5) Infection Therapeutic Drugs Market Trends
Table 11. Cytomegalovirus (HHV-5) Infection Therapeutic Drugs Market Drivers
Table 12. Cytomegalovirus (HHV-5) Infection Therapeutic Drugs Market Challenges
Table 13. Cytomegalovirus (HHV-5) Infection Therapeutic Drugs Market Restraints
Table 14. Global Cytomegalovirus (HHV-5) Infection Therapeutic Drugs Revenue by Players (2019-2024) & (US$ Million)
Table 15. Global Cytomegalovirus (HHV-5) Infection Therapeutic Drugs Market Share by Players (2019-2024)
Table 16. Global Top Cytomegalovirus (HHV-5) Infection Therapeutic Drugs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cytomegalovirus (HHV-5) Infection Therapeutic Drugs as of 2023)
Table 17. Ranking of Global Top Cytomegalovirus (HHV-5) Infection Therapeutic Drugs Companies by Revenue (US$ Million) in 2023
Table 18. Global 5 Largest Players Market Share by Cytomegalovirus (HHV-5) Infection Therapeutic Drugs Revenue (CR5 and HHI) & (2019-2024)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Cytomegalovirus (HHV-5) Infection Therapeutic Drugs Product Solution and Service
Table 21. Date of Enter into Cytomegalovirus (HHV-5) Infection Therapeutic Drugs Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Cytomegalovirus (HHV-5) Infection Therapeutic Drugs Market Size by Type (2019-2024) & (US$ Million)
Table 24. Global Cytomegalovirus (HHV-5) Infection Therapeutic Drugs Revenue Market Share by Type (2019-2024)
Table 25. Global Cytomegalovirus (HHV-5) Infection Therapeutic Drugs Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 26. Global Cytomegalovirus (HHV-5) Infection Therapeutic Drugs Revenue Market Share by Type (2025-2030)
Table 27. Global Cytomegalovirus (HHV-5) Infection Therapeutic Drugs Market Size by Application (2019-2024) & (US$ Million)
Table 28. Global Cytomegalovirus (HHV-5) Infection Therapeutic Drugs Revenue Market Share by Application (2019-2024)
Table 29. Global Cytomegalovirus (HHV-5) Infection Therapeutic Drugs Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 30. Global Cytomegalovirus (HHV-5) Infection Therapeutic Drugs Revenue Market Share by Application (2025-2030)
Table 31. North America Cytomegalovirus (HHV-5) Infection Therapeutic Drugs Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 32. North America Cytomegalovirus (HHV-5) Infection Therapeutic Drugs Market Size by Country (2019-2024) & (US$ Million)
Table 33. North America Cytomegalovirus (HHV-5) Infection Therapeutic Drugs Market Size by Country (2025-2030) & (US$ Million)
Table 34. Europe Cytomegalovirus (HHV-5) Infection Therapeutic Drugs Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 35. Europe Cytomegalovirus (HHV-5) Infection Therapeutic Drugs Market Size by Country (2019-2024) & (US$ Million)
Table 36. Europe Cytomegalovirus (HHV-5) Infection Therapeutic Drugs Market Size by Country (2025-2030) & (US$ Million)
Table 37. Asia-Pacific Cytomegalovirus (HHV-5) Infection Therapeutic Drugs Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030
Table 38. Asia-Pacific Cytomegalovirus (HHV-5) Infection Therapeutic Drugs Market Size by Region (2019-2024) & (US$ Million)
Table 39. Asia-Pacific Cytomegalovirus (HHV-5) Infection Therapeutic Drugs Market Size by Region (2025-2030) & (US$ Million)
Table 40. Latin America Cytomegalovirus (HHV-5) Infection Therapeutic Drugs Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 41. Latin America Cytomegalovirus (HHV-5) Infection Therapeutic Drugs Market Size by Country (2019-2024) & (US$ Million)
Table 42. Latin America Cytomegalovirus (HHV-5) Infection Therapeutic Drugs Market Size by Country (2025-2030) & (US$ Million)
Table 43. Middle East & Africa Cytomegalovirus (HHV-5) Infection Therapeutic Drugs Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 44. Middle East & Africa Cytomegalovirus (HHV-5) Infection Therapeutic Drugs Market Size by Country (2019-2024) & (US$ Million)
Table 45. Middle East & Africa Cytomegalovirus (HHV-5) Infection Therapeutic Drugs Market Size by Country (2025-2030) & (US$ Million)
Table 46. 3-V Biosciences, Inc. Company Detail
Table 47. 3-V Biosciences, Inc. Business Overview
Table 48. 3-V Biosciences, Inc. Cytomegalovirus (HHV-5) Infection Therapeutic Drugs Product
Table 49. 3-V Biosciences, Inc. Revenue in Cytomegalovirus (HHV-5) Infection Therapeutic Drugs Business (2019-2024) & (US$ Million)
Table 50. 3-V Biosciences, Inc. Recent Development
Table 51. AIMM Therapeutics Company Detail
Table 52. AIMM Therapeutics Business Overview
Table 53. AIMM Therapeutics Cytomegalovirus (HHV-5) Infection Therapeutic Drugs Product
Table 54. AIMM Therapeutics Revenue in Cytomegalovirus (HHV-5) Infection Therapeutic Drugs Business (2019-2024) & (US$ Million)
Table 55. AIMM Therapeutics Recent Development
Table 56. AlphaVax Company Detail
Table 57. AlphaVax Business Overview
Table 58. AlphaVax Cytomegalovirus (HHV-5) Infection Therapeutic Drugs Product
Table 59. AlphaVax Revenue in Cytomegalovirus (HHV-5) Infection Therapeutic Drugs Business (2019-2024) & (US$ Million)
Table 60. AlphaVax Recent Development
Table 61. Altor BioScience Company Detail
Table 62. Altor BioScience Business Overview
Table 63. Altor BioScience Cytomegalovirus (HHV-5) Infection Therapeutic Drugs Product
Table 64. Altor BioScience Revenue in Cytomegalovirus (HHV-5) Infection Therapeutic Drugs Business (2019-2024) & (US$ Million)
Table 65. Altor BioScience Recent Development
Table 66. Applied Immune Company Detail
Table 67. Applied Immune Business Overview
Table 68. Applied Immune Cytomegalovirus (HHV-5) Infection Therapeutic Drugs Product
Table 69. Applied Immune Revenue in Cytomegalovirus (HHV-5) Infection Therapeutic Drugs Business (2019-2024) & (US$ Million)
Table 70. Applied Immune Recent Development
Table 71. Astellas Company Detail
Table 72. Astellas Business Overview
Table 73. Astellas Cytomegalovirus (HHV-5) Infection Therapeutic Drugs Product
Table 74. Astellas Revenue in Cytomegalovirus (HHV-5) Infection Therapeutic Drugs Business (2019-2024) & (US$ Million)
Table 75. Astellas Recent Development
Table 76. BioApex Company Detail
Table 77. BioApex Business Overview
Table 78. BioApex Cytomegalovirus (HHV-5) Infection Therapeutic Drugs Product
Table 79. BioApex Revenue in Cytomegalovirus (HHV-5) Infection Therapeutic Drugs Business (2019-2024) & (US$ Million)
Table 80. BioApex Recent Development
Table 81. Bionor Pharma Company Detail
Table 82. Bionor Pharma Business Overview
Table 83. Bionor Pharma Cytomegalovirus (HHV-5) Infection Therapeutic Drugs Product
Table 84. Bionor Pharma Revenue in Cytomegalovirus (HHV-5) Infection Therapeutic Drugs Business (2019-2024) & (US$ Million)
Table 85. Bionor Pharma Recent Development
Table 86. Biotest Company Detail
Table 87. Biotest Business Overview
Table 88. Biotest Cytomegalovirus (HHV-5) Infection Therapeutic Drugs Product
Table 89. Biotest Revenue in Cytomegalovirus (HHV-5) Infection Therapeutic Drugs Business (2019-2024) & (US$ Million)
Table 90. Biotest Recent Development
Table 91. Pfizer Company Detail
Table 92. Pfizer Business Overview
Table 93. Pfizer Cytomegalovirus (HHV-5) Infection Therapeutic Drugs Product
Table 94. Pfizer Revenue in Cytomegalovirus (HHV-5) Infection Therapeutic Drugs Business (2019-2024) & (US$ Million)
Table 95. Pfizer Recent Development
Table 96. Cell Medica Company Detail
Table 97. Cell Medica Business Overview
Table 98. Cell Medica Cytomegalovirus (HHV-5) Infection Therapeutic Drugs Product
Table 99. Cell Medica Revenue in Cytomegalovirus (HHV-5) Infection Therapeutic Drugs Business (2019-2024) & (US$ Million)
Table 100. Cell Medica Recent Development
Table 101. Chimerix Company Detail
Table 102. Chimerix Business Overview
Table 103. Chimerix Cytomegalovirus (HHV-5) Infection Therapeutic Drugs Product
Table 104. Chimerix Revenue in Cytomegalovirus (HHV-5) Infection Therapeutic Drugs Business (2019-2024) & (US$ Million)
Table 105. Chimerix Recent Development
Table 106. GSK Company Detail
Table 107. GSK Business Overview
Table 108. GSK Cytomegalovirus (HHV-5) Infection Therapeutic Drugs Product
Table 109. GSK Revenue in Cytomegalovirus (HHV-5) Infection Therapeutic Drugs Business (2019-2024) & (US$ Million)
Table 110. GSK Recent Development
Table 111. Hookipa Biotech Company Detail
Table 112. Hookipa Biotech Business Overview
Table 113. Hookipa Biotech Cytomegalovirus (HHV-5) Infection Therapeutic Drugs Product
Table 114. Hookipa Biotech Revenue in Cytomegalovirus (HHV-5) Infection Therapeutic Drugs Business (2019-2024) & (US$ Million)
Table 115. Hookipa Biotech Recent Development
Table 116. Humabs BioMed Company Detail
Table 117. Humabs BioMed Business Overview
Table 118. Humabs BioMed Cytomegalovirus (HHV-5) Infection Therapeutic Drugs Product
Table 119. Humabs BioMed Revenue in Cytomegalovirus (HHV-5) Infection Therapeutic Drugs Business (2019-2024) & (US$ Million)
Table 120. Humabs BioMed Recent Development
Table 121. Inagen Company Detail
Table 122. Inagen Business Overview
Table 123. Inagen Cytomegalovirus (HHV-5) Infection Therapeutic Drugs Product
Table 124. Inagen Revenue in Cytomegalovirus (HHV-5) Infection Therapeutic Drugs Business (2019-2024) & (US$ Million)
Table 125. Inagen Recent Development
Table 126. Kadmon Corporation Company Detail
Table 127. Kadmon Corporation Business Overview
Table 128. Kadmon Corporation Cytomegalovirus (HHV-5) Infection Therapeutic Drugs Product
Table 129. Kadmon Corporation Revenue in Cytomegalovirus (HHV-5) Infection Therapeutic Drugs Business (2019-2024) & (US$ Million)
Table 130. Kadmon Corporation Recent Development
Table 131. Lead Discovery Center Company Detail
Table 132. Lead Discovery Center Business Overview
Table 133. Lead Discovery Center Cytomegalovirus (HHV-5) Infection Therapeutic Drugs Product
Table 134. Lead Discovery Center Revenue in Cytomegalovirus (HHV-5) Infection Therapeutic Drugs Business (2019-2024) & (US$ Million)
Table 135. Lead Discovery Center Recent Development
Table 136. Merck Company Detail
Table 137. Merck Business Overview
Table 138. Merck Cytomegalovirus (HHV-5) Infection Therapeutic Drugs Product
Table 139. Merck Revenue in Cytomegalovirus (HHV-5) Infection Therapeutic Drugs Business (2019-2024) & (US$ Million)
Table 140. Merck Recent Development
Table 141. Novartis Company Detail
Table 142. Novartis Business Overview
Table 143. Novartis Cytomegalovirus (HHV-5) Infection Therapeutic Drugs Product
Table 144. Novartis Revenue in Cytomegalovirus (HHV-5) Infection Therapeutic Drugs Business (2019-2024) & (US$ Million)
Table 145. Novartis Recent Development
Table 146. Research Programs/Design for This Report
Table 147. Key Data Information from Secondary Sources
Table 148. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Cytomegalovirus (HHV-5) Infection Therapeutic Drugs Market Size Comparison by Type (2024-2030) & (US$ Million)
Figure 2. Global Cytomegalovirus (HHV-5) Infection Therapeutic Drugs Market Share by Type: 2023 VS 2030
Figure 3. Oral Medication Features
Figure 4. Injection Features
Figure 5. Global Cytomegalovirus (HHV-5) Infection Therapeutic Drugs Market Size Comparison by Application (2024-2030) & (US$ Million)
Figure 6. Global Cytomegalovirus (HHV-5) Infection Therapeutic Drugs Market Share by Application: 2023 VS 2030
Figure 7. Hospital Case Studies
Figure 8. Clinic Case Studies
Figure 9. Other Case Studies
Figure 10. Cytomegalovirus (HHV-5) Infection Therapeutic Drugs Report Years Considered
Figure 11. Global Cytomegalovirus (HHV-5) Infection Therapeutic Drugs Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 12. Global Cytomegalovirus (HHV-5) Infection Therapeutic Drugs Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 13. Global Cytomegalovirus (HHV-5) Infection Therapeutic Drugs Market Share by Region: 2023 VS 2030
Figure 14. Global Cytomegalovirus (HHV-5) Infection Therapeutic Drugs Market Share by Players in 2023
Figure 15. Global Top Cytomegalovirus (HHV-5) Infection Therapeutic Drugs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cytomegalovirus (HHV-5) Infection Therapeutic Drugs as of 2023)
Figure 16. The Top 10 and 5 Players Market Share by Cytomegalovirus (HHV-5) Infection Therapeutic Drugs Revenue in 2023
Figure 17. North America Cytomegalovirus (HHV-5) Infection Therapeutic Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 18. North America Cytomegalovirus (HHV-5) Infection Therapeutic Drugs Market Share by Country (2019-2030)
Figure 19. United States Cytomegalovirus (HHV-5) Infection Therapeutic Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 20. Canada Cytomegalovirus (HHV-5) Infection Therapeutic Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 21. Europe Cytomegalovirus (HHV-5) Infection Therapeutic Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 22. Europe Cytomegalovirus (HHV-5) Infection Therapeutic Drugs Market Share by Country (2019-2030)
Figure 23. Germany Cytomegalovirus (HHV-5) Infection Therapeutic Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 24. France Cytomegalovirus (HHV-5) Infection Therapeutic Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 25. U.K. Cytomegalovirus (HHV-5) Infection Therapeutic Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 26. Italy Cytomegalovirus (HHV-5) Infection Therapeutic Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 27. Russia Cytomegalovirus (HHV-5) Infection Therapeutic Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 28. Nordic Countries Cytomegalovirus (HHV-5) Infection Therapeutic Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 29. Asia-Pacific Cytomegalovirus (HHV-5) Infection Therapeutic Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 30. Asia-Pacific Cytomegalovirus (HHV-5) Infection Therapeutic Drugs Market Share by Region (2019-2030)
Figure 31. China Cytomegalovirus (HHV-5) Infection Therapeutic Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 32. Japan Cytomegalovirus (HHV-5) Infection Therapeutic Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 33. South Korea Cytomegalovirus (HHV-5) Infection Therapeutic Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 34. Southeast Asia Cytomegalovirus (HHV-5) Infection Therapeutic Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 35. India Cytomegalovirus (HHV-5) Infection Therapeutic Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 36. Australia Cytomegalovirus (HHV-5) Infection Therapeutic Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 37. Latin America Cytomegalovirus (HHV-5) Infection Therapeutic Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 38. Latin America Cytomegalovirus (HHV-5) Infection Therapeutic Drugs Market Share by Country (2019-2030)
Figure 39. Mexico Cytomegalovirus (HHV-5) Infection Therapeutic Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 40. Brazil Cytomegalovirus (HHV-5) Infection Therapeutic Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 41. Middle East & Africa Cytomegalovirus (HHV-5) Infection Therapeutic Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 42. Middle East & Africa Cytomegalovirus (HHV-5) Infection Therapeutic Drugs Market Share by Country (2019-2030)
Figure 43. Turkey Cytomegalovirus (HHV-5) Infection Therapeutic Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 44. Saudi Arabia Cytomegalovirus (HHV-5) Infection Therapeutic Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 45. 3-V Biosciences, Inc. Revenue Growth Rate in Cytomegalovirus (HHV-5) Infection Therapeutic Drugs Business (2019-2024)
Figure 46. AIMM Therapeutics Revenue Growth Rate in Cytomegalovirus (HHV-5) Infection Therapeutic Drugs Business (2019-2024)
Figure 47. AlphaVax Revenue Growth Rate in Cytomegalovirus (HHV-5) Infection Therapeutic Drugs Business (2019-2024)
Figure 48. Altor BioScience Revenue Growth Rate in Cytomegalovirus (HHV-5) Infection Therapeutic Drugs Business (2019-2024)
Figure 49. Applied Immune Revenue Growth Rate in Cytomegalovirus (HHV-5) Infection Therapeutic Drugs Business (2019-2024)
Figure 50. Astellas Revenue Growth Rate in Cytomegalovirus (HHV-5) Infection Therapeutic Drugs Business (2019-2024)
Figure 51. BioApex Revenue Growth Rate in Cytomegalovirus (HHV-5) Infection Therapeutic Drugs Business (2019-2024)
Figure 52. Bionor Pharma Revenue Growth Rate in Cytomegalovirus (HHV-5) Infection Therapeutic Drugs Business (2019-2024)
Figure 53. Biotest Revenue Growth Rate in Cytomegalovirus (HHV-5) Infection Therapeutic Drugs Business (2019-2024)
Figure 54. Pfizer Revenue Growth Rate in Cytomegalovirus (HHV-5) Infection Therapeutic Drugs Business (2019-2024)
Figure 55. Cell Medica Revenue Growth Rate in Cytomegalovirus (HHV-5) Infection Therapeutic Drugs Business (2019-2024)
Figure 56. Chimerix Revenue Growth Rate in Cytomegalovirus (HHV-5) Infection Therapeutic Drugs Business (2019-2024)
Figure 57. GSK Revenue Growth Rate in Cytomegalovirus (HHV-5) Infection Therapeutic Drugs Business (2019-2024)
Figure 58. Hookipa Biotech Revenue Growth Rate in Cytomegalovirus (HHV-5) Infection Therapeutic Drugs Business (2019-2024)
Figure 59. Humabs BioMed Revenue Growth Rate in Cytomegalovirus (HHV-5) Infection Therapeutic Drugs Business (2019-2024)
Figure 60. Inagen Revenue Growth Rate in Cytomegalovirus (HHV-5) Infection Therapeutic Drugs Business (2019-2024)
Figure 61. Kadmon Corporation Revenue Growth Rate in Cytomegalovirus (HHV-5) Infection Therapeutic Drugs Business (2019-2024)
Figure 62. Lead Discovery Center Revenue Growth Rate in Cytomegalovirus (HHV-5) Infection Therapeutic Drugs Business (2019-2024)
Figure 63. Merck Revenue Growth Rate in Cytomegalovirus (HHV-5) Infection Therapeutic Drugs Business (2019-2024)
Figure 64. Novartis Revenue Growth Rate in Cytomegalovirus (HHV-5) Infection Therapeutic Drugs Business (2019-2024)
Figure 65. Bottom-up and Top-down Approaches for This Report
Figure 66. Data Triangulation
Figure 67. Key Executives Interviewed